A novel oral indoline-sulfonamide agent, N-[1-(4-methoxybenzenesulfonyl)-2, 3-dihydro-1H-indol-7-yl]-isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule
Jing Ping Liou, Kuo Shun Hsu, Ching Chuan Kuo, Chi Yen Chang, Jang Yang Chang
研究成果: 雜誌貢獻 › 文章 › 同行評審
62
引文
斯高帕斯(Scopus)